Etofibrate – 5 mg

Brand:
Cayman
CAS:
31637-97-5
Storage:
-20
UN-No:
Non-Hazardous - /

Etofibrate is a combination of niacin and clofibrate (Item No. 10956) that acts as a hypolipidemic agent.{39206} In vivo, etofibrate decreases plasma cholesterol and triglyceride concentrations and increases bile cholesterol content in rats.{39206,39207} It also decreases thromboxane formation, platelet aggregation, and plasma viscosity and inhibits neointima formation in a carotid artery balloon injury rat model.{39208} Formulations containing etofibrate have been used to treat hyperlipidemia.  

 

Out of stock

SKU: 21022 - Category:

Description

A hypolipidemic agent; a combination of niacin and clofibrate; decreases plasma cholesterol and triglyceride concentrations and increases bile cholesterol content in rats; decreases thromboxane formation, platelet aggregation, and plasma viscosity and inhibits neointima formation in a carotid artery balloon injury rat model,


Formal name: 3-pyridinecarboxylic acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl ester

Synonyms:  Nicotinic Acid

Molecular weight: 363.8

CAS: 31637-97-5

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Blood|Coagulation & Hemostasis||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Lipids & Lipoproteins||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias